Ablacon
Signal active
Organization
Contact Information
Overview
Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation (AF).Their technology visualizes in real-time what is going on in the heart. They compute the electrographic flow which allows to treat atrial fibrillation faster, more precisely and more reliably.
About
Industries
Artificial Intelligence (AI), Machine Learning, Therapeutics
Founded
2015
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Ablacon headquartered in United States, North America, operates in the Artificial Intelligence (AI), Machine Learning, Therapeutics sector. The company focuses on Artificial Intelligence (AI) and has secured $3.0B in funding across 48 round(s). With a team of 11-50 employees, Ablacon is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Series B - Ablacon, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$63.5M
Details
3
Ablacon has raised a total of $63.5M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 21.5M | ||
| 2019 | Early Stage Venture | 2.0M | ||
| 2021 | Early Stage Venture | 30.0M |
Investors
Ablacon is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Ablacon | - | FUNDING ROUND - Ablacon | 10.0M |
| Western Technology Investment | - | FUNDING ROUND - Western Technology Investment | 10.0M |
| Ablacon | - | FUNDING ROUND - Ablacon | 30.0M |
| Zeus Health | - | FUNDING ROUND - Zeus Health | 30.0M |
Recent Activity
There is no recent news or activity for this profile.